Cancer is different from person to person. Each individual responds uniquely to treatment.
Functional profiling uses a patient’s own cancer cells to see how they respond to different drugs or drug combinations. This testing takes place outside of a patient’s body. Cancer cells survive longer than other cells. Studying cell death provides insight into treatment.
Peer reviewed publications show the success rate of functional profiling at 44 percent improvement at one year of survival.
Listen as Dr. Robert Nagourney joins Dr. Mike Smith to discuss innovations in future cancer treatment.
Selected Podcast
Profiling Cancer Cells
Featuring:
Over the past 20+ years, Dr. Nagourney and his team at the Nagourney Cancer Institute have developed a laboratory technique, FUNCTIONAL PROFILING, that measures how cancer cells respond when they are exposed to a wide variety of drugs and drug combinations.
Why is this important? By using this approach, they try to determine in the laboratory the best drugs for each patient before they receive them. This reduces the guesswork in selecting the right drug treatment for you and is why their analysis is more powerful than genomic testing offered by most centers.
Robert Nagourney, MD
Dr. Robert Nagourney is founder and director of Nagourney Cancer Institute, an accomplished research and testing lab in Long Beach, California personalizing cancer treatments for global patients. Dr. Nagourney is author of the book "Outliving Cancer", a former TEDx speaker, an active blogger, practicing oncologist, and clinical professor at the University of California, Irvine. He is an internationally recognized pioneer in cancer research and personalized cancer treatment. With more than 20 years experience in human tumor primary culture analyses, Dr. Nagourney has authored more than 100 manuscripts, book chapters and abstracts including publications in the Journal of Clinical Oncology, Gynecologic Oncology and the Journal of the National Cancer Institute.Over the past 20+ years, Dr. Nagourney and his team at the Nagourney Cancer Institute have developed a laboratory technique, FUNCTIONAL PROFILING, that measures how cancer cells respond when they are exposed to a wide variety of drugs and drug combinations.
Why is this important? By using this approach, they try to determine in the laboratory the best drugs for each patient before they receive them. This reduces the guesswork in selecting the right drug treatment for you and is why their analysis is more powerful than genomic testing offered by most centers.